Kuva Labs delays tender offer for Lisata to June 10; outside date extended to July 17

LISATA THERAPEUTICS, INC.

Tender offer commencement deadline extended from June 1 to June 10, 2026; company waives claims for previous delay.
Outside date extended from July 1 to July 17, 2026; Parent may pay $1.5M non-refundable fee to extend to August 17.
Parent acknowledges no committed financing; plans up to $25M in convertible notes from JBA Asset Management only non-binding.
Company waives $250K interim operating payment default in exchange for $150K on June 12 and $100K on June 26.
Lisata covenants not to sue until June 10; termination rights if Parent breaches.

item 1.01 item 9.01

Featured in Daily 8-K Digest

Selected #7 for 2026-06-09. Read digest

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

LISATA THERAPEUTICS, INC. amended Amendment and Waiver to Agreement and Plan of Merger with Kuva Labs Inc. valued at Amendment extends tender offer commencement date to June 10, 2026, extends Outside Date to July 17, (effective 2026-06-08).

Action: amendment
Agreement: merger
Counterparty: Kuva Labs Inc.
Value: Amendment extends tender offer commencement date to June 10, 2026, extends Outside Date to July 17,
Effective: 2026-06-08

Exact text from the filing

On June 8, 2026, Lisata Therapeutics, Inc. (the "Company" or "Lisata") and Kuva Labs Inc., a Delaware corporation ("Parent"), together with Kuva Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent ("Purchaser"), entered into an amendment and waiver (the "Amendment") to the previously announced Agreement and Plan of Merger, dated as of March 6, 2026, by and among Parent, Purchaser and the Company (as it may be amended from time to time, the "Merger Agreement").

View on SEC.gov

745 material agreements filed in the last 30 days. Browse all material agreements →

LISATA THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001140361-26-024560

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.